Bioceltix Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 28, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	436	431	372	133	172
Market Cap Growth	-7.52%	16.07%	179.48%	-22.49%	-
Enterprise Value	413	394	357	130	-
Last Close Price	88.60	87.60	90.00	38.80	52.20
PB Ratio	16.16	11.23	35.51	25.82	28.60
P/TBV Ratio	16.16	11.23	35.51	25.82	28.60
Debt / Equity Ratio	0.02	0.02	0.02	0.06	0.09
Net Debt / Equity Ratio	-0.87	-0.85	-0.87	-0.74	-0.92
Net Debt / EBITDA Ratio	1.65	2.26	0.67	0.45	1.37
Net Debt / FCF Ratio	1.79	1.84	0.60	0.47	1.37
Inventory Turnover	84.10	126.03	-	-	-
Quick Ratio	8.51	12.08	5.23	1.94	3.41
Current Ratio	8.83	12.34	5.24	2.68	3.42
Return on Equity (ROE)	-43.22%	-60.95%	-175.28%	-160.02%	-
Return on Assets (ROA)	-25.14%	-34.54%	-85.92%	-70.62%	-
Return on Capital Employed (ROCE)	-55.10%	-39.00%	-132.30%	-165.70%	-70.00%
Earnings Yield	-3.39%	-3.45%	-3.68%	-6.71%	-2.56%
FCF Yield	-3.01%	-4.13%	-4.09%	-6.19%	-2.35%
Buyback Yield / Dilution	-25.36%	-15.76%	-17.48%	-5.54%	-

Source: S&P Capital IQ. Standard template. Financial Sources.